aod9604 clinical trial doses AOD-9604 Dosage Guide: Complete Protocol for Safe Administration AOD 9604: The Complete Evidence-Based

This includes measuring glycerol and free fatty acids as indicators of fat metabolism

Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604

5-Amino-1MQ is currently available in oral form

In 2000, a research study was carried out in obese Zucker rats where the AOD 9604 peptide was given daily for 19 consecutive days

Proper dosing protocolstypically 250-500 mcg daily via subcutaneous injection in a fasted stateprovide the foundation for optimal results while minimizing side effects